Viracell

ViraCell is a French Contract Development and Manufacturing Organization (CDMO) specializing in the production of viral vectors for cell and gene therapies. The company focuses on providing high-quality Adeno-Associated Virus (AAV) and Lentivirus vectors to support biotechnology and pharmaceutical companies from early-stage research through clinical development. ViraCell leverages advanced bioprocessing technologies to optimize yield and purity, addressing the critical bottleneck in the supply of viral delivery systems. Their services include process development, analytical testing, and GMP-compliant manufacturing. Based in Saint-Etienne, ViraCell aims to accelerate the path to clinic for advanced therapy medicinal products (ATMPs). The company's expertise spans both suspension and adherent cell culture systems to meet diverse client needs.